Cargando…
miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway
miR-186-3p acts as a tumor suppressor in various cancers. This study aimed to explore the expression levels of miR-186-3p and its role in cervical cancer. We analyzed the effects of miR-186-3p and insulin-like growth factor 1 (IGF1) on the proliferation, invasion, and apoptosis of cervical cancer ce...
Autores principales: | Lu, Xiurong, Song, Xiao, Hao, Xiaohui, Liu, Xiaoyu, Zhang, Xianyu, Yuan, Na, Ma, Huan, Zhang, Zhilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806770/ https://www.ncbi.nlm.nih.gov/pubmed/34551673 http://dx.doi.org/10.1080/21655979.2021.1977053 |
Ejemplares similares
-
MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1
por: Lu, Xiurong, et al.
Publicado: (2021) -
MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2
por: Lu, Xiurong, et al.
Publicado: (2021) -
A Research Study to Measure the Efficacy of Terminating Cervical Cancer via Customized Optimum Pathway
por: Zhang, Xianyu, et al.
Publicado: (2022) -
miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer
por: Wang, Zhongrui, et al.
Publicado: (2023) -
miRNA-186 Improves Sepsis Induced Renal Injury Via PTEN/PI3K/AKT/P53 Pathway
por: Li, Min, et al.
Publicado: (2020)